Loading data for NONOF — first visit, this takes a few seconds.
Novo Nordisk A/S (NONOF)
OTC Markets OTCPK: NONOF
· 即時價格 · USD
43.00
-1.00 (-2.27%)
收盤價： Sep 11, 2026, 10:11 AM
股價、關鍵數字和最新消息，都在這一頁。
Novo Nordisk A/S（NONOF）股價、分析與資料
-2.27% (1D)
| 買價 | 42.13 |
| 市值 | 190B |
| 營收 (ttm) | 329B |
| 淨利（ttm） | 116B |
| 0.34 | |
| 4.08 | |
| 10.54 | |
| n/a | |
| P/B (ttm) | 5.55 |
| P/S (ttm) | 0.58 |
| 財報日期 | Nov 4, 2026 |
| 賣價 | 43 |
| 成交量 | 1,000 |
| 20 日平均成交量 | 66,051 |
| 開盤價 | 43.00 |
| 前收盤價 | 44.00 |
| 當日區間 | 43.00 - 43.00 |
| 52 週範圍 | 34.00 - 64.75 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | $1.80 (4.08%) |
| 除息日 | Aug 14, 2026 |
關於 NONOF
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine...
完整的公司簡介財報驚奇
Novo Nordisk A/S 已於 Invalid Date 公布季度財報：
- 營收為 n/a 低於預期 $0, 年增 NaN% 成長.
- 每股盈餘為 低於預期 , 年增 NaN% 成長.
第 1 頁，共 2 頁